In this study, we identified ANGPTL4, ANGPTL3, and endostatin as angiogenesis-related proteins that are independently associated with 2-year MACEs in patients with PAD, potentially serving as prognostic biomarkers. The gene discussed is ANGPTL4; the disease is peripheral arterial disease.